Patients with chronic kidney disease (CKD) exhibit an elevated cardiovascular risk
manifesting as coronary artery disease, heart failure, arrhythmias, and sudden cardiac …

Health professionals are encouraged to take the ESC/EACTS Guidelines fully into account
when exercising their clinical judgment, as well as in the determination and the …

The recommendations listed in this document are, whenever possible, evidence based. An
extensive review was conducted on literature published through March 1, 2020. Searches …

Aim This executive summary of the valvular heart disease guideline provides
recommendations for clinicians to diagnose and manage valvular heart disease as well as …

Importance Transcatheter aortic valve implantation (TAVI) is a less invasive alternative to
surgical aortic valve replacement and is the treatment of choice for patients at high operative …

Aims The respective roles of oral anticoagulation or antiplatelet therapy following
transcatheter aortic valve implantation (TAVI) remain debated. ATLANTIS is an international …

This report from the European Society of Cardiology (ESC) Atlas Project updates and
expands upon the 2021 report in presenting cardiovascular disease (CVD) statistics for the …

Background: Few randomized trials have compared bioprostheses for transcatheter aortic
valve replacement, and no trials have compared bioprostheses with supra-annular design …

Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Aims Additional randomized clinical trial (RCT) data comparing transcatheter aortic valve
implantation (TAVI) with surgical aortic valve replacement (SAVR) is available, including …